Article
<em>Trypanosoma cruzi</em> STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
2023-08-31
Abstract excerpt
Since the first published genome sequence of Trypanosoma cruzi in 2005, there has been tremendous technological advance in genomics, reverse genetics, and assay development for this elusive pathogen. However, there is still an unmet need for new and better drugs to treat Chagas disease. Here we introduce a T. cruzi assay strain that is useful for drug research as well as basic studies in host-pathogen interaction....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5056d347-866b-56a4-83e1-d9d51f57a039
- DOI
- 10.20944/preprints202308.2120.v1
